Prostatis Group’s Schwab US Dividend Equity ETF SCHD Stock Holding History

Prostatis Group’s Portfolio SCHD Stock Details SCHD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-15,298	Closed	-$469K	–	198
2026 Q1	$469K	Buy	+15,298	New	+$464K	0.12%	108
2023 Q3	–	Sell	-197,337	Closed	-$75.2K	–	207
2023 Q2	$75.2K	Buy	+197,337	New	+$4.71M	0.04%	149

Other funds holding SCHD

SLI

Sumitomo Life Insurance Tokyo, Japan $6.12B AUM 21.82% 1-Year Est. Return

RIM

Rakuten Investment Management Tokyo, Japan $34.6B AUM 29.24% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

WANY

Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return

Prostatis Group's SCHD Position: Q2 2026 in Review

Prostatis Group sold out of Schwab US Dividend Equity ETF (SCHD) in Q2 2026, closing a stake of 15,298 shares — an estimated $469K sold.

Prostatis Group first reported a position in SCHD in Q2 2023 and held it in 2 quarters. The position peaked at $469K in Q1 2026. 2,131 funds tracked by Wall St. Rank hold SCHD as of Q2 2026.

Prostatis Group reported no remaining Schwab US Dividend Equity ETF position as of Q2 2026 after selling out during the quarter.
Prostatis Group sold 15,298 Schwab US Dividend Equity ETF shares in Q2 2026, an estimated $469K.
Prostatis Group first reported a position in Schwab US Dividend Equity ETF in Q2 2023 and held it in 2 quarters.
Prostatis Group's Schwab US Dividend Equity ETF position peaked at $469K in Q1 2026.
2,131 funds tracked by Wall St. Rank held Schwab US Dividend Equity ETF as of Q2 2026.

Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.